Sign in
Taking peopleNo phase

Red glow on scalp imaging and hair regrowth in patchy alopecia areata

Studies whether red glow in scalp images relates to regrowth after steroid injections.

Key facts

Who runs it
Istanbul Training and Research Hospital
Where
Türkiye1 site in 1 countryChoose a country to see its sites
Trial code
Registry title
UV-Trichoscopic Red Fluorescence in Alopecia Areata
Status
Recruiting
People taking part
40 people, planned
Started
1 Jul 2026
Expected to end
Dec 2026
Type of study
Observational
Treatments tested
  • Triamcinolone Acetonide
Record updated
11 September 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults with a small, patchy form of alopecia areata (patchy hair loss) on the scalp. Their doctors must already plan steroid injections into the bald patches as part of their usual care.

Age
18 years or older
Sex
All sexes
Disease stage
Limited plaque-type (patchy) alopecia areata of the scalp, with active hair loss, starting within the previous 6 months
Earlier treatment
No treatment for alopecia areata on the skin, as an injection into muscle, or by mouth in the previous 1 month. No steroid injections into the patches in the previous 6 weeks.

Main reasons for not taking part

  • Alopecia areata of the beard, or very widespread hair loss or several large patches
  • Fungal scalp infection (tinea capitis) or any active infection
  • Current light therapy (phototherapy), or recent medicines that weaken the immune system
  • Pregnancy or breastfeeding
  • A medical reason not to have UV imaging

The registry criteria, word for word

Show all 14 criteriaShow less

Who can take part

  • Age 18 years or older
  • Limited plaque-type alopecia areata of the scalp
  • Active hair loss
  • Symptom onset within the previous 6 months
  • No topical, intramuscular, or oral treatment for alopecia areata within the previous 1 month
  • No intralesional corticosteroid treatment within the previous 6 weeks
  • Provision of informed consent

Who cannot take part

  • Systemic immunosuppressive treatment within the washout period specified in the study protocol
  • Tinea capitis or active infection
  • Beard alopecia areata
  • Very extensive alopecia areata or multiple large plaques
  • Current phototherapy
  • Pregnancy or breastfeeding
  • Contraindication to UV imaging

This trial is currently available in Türkiye.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

The goal of this observational study is to learn whether red fluorescence seen with ultraviolet (UV) trichoscopy is related to disease findings and treatment response in adults with limited plaque-type alopecia areata. Trichoscopy is a close-up imaging method used to examine the hair and scalp. The study will investigate whether the amount of red fluorescence at the beginning of the study is related to how soon hair starts to grow back, how much hair regrows, and how trichoscopic findings change during follow-up. Participants for whom intralesional corticosteroid treatment has been planned as part of their regular medical care will have standard trichoscopic and UV-trichoscopic images taken of the affected scalp area. They will be followed at weeks 4, 8, and 12, when hair regrowth and changes in scalp and hair findings will be evaluated. Researchers will measure red fluorescence in the images and examine whether it is related to treatment response over time.

The group in the trial

  • Limited Plaque-Type Alopecia Areata

    Adults with limited plaque-type alopecia areata who are receiving intralesional corticosteroid treatment as part of routine clinical care. Participants will undergo conventional trichoscopic and UV-trichoscopic assessments at baseline and during follow-up at weeks 4, 8, and 12. Hair regrowth, trichoscopic findings, and UV-trichoscopic red fluorescence intensity will be evaluated over time.

    Treatment: Triamcinolone Acetonide

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Evaluation of UV-Trichoscopic Red Fluorescence Intensity in Relation to Trichoscopic Findings and Response to Intralesional Corticosteroid Treatment in Limited Plaque-Type Alopecia Areata
Plain-language title
Red glow on scalp imaging and hair regrowth in patchy alopecia areataGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 14 November 2026.
Record updated
11 September 2026